Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sinohealth Holdings Ltd. ( (HK:2361) ) has shared an announcement.
Sinohealth Technology Holdings has disclosed that its current public float stands at about 16.45%, below the Hong Kong listing requirement of 25%, mainly because 8.84% of its issued shares are held by a trustee under a share award scheme and therefore excluded from the public float calculation. The company has detailed a multi-pronged plan to restore compliance, balancing incentive grants with measures to broaden its investor base.
Management plans to grant the remaining share awards over the next three years to non-core connected participants, tying allocations to company performance and individual appraisals to support medium- to long-term growth. In parallel, Sinohealth aims to boost its free float by at least eight percentage points by June 2027 through potential equity financing and encouraging major shareholders to place shares with independent investors, while committing to monthly market updates until the public float is restored.
More about Sinohealth Holdings Ltd.
Sinohealth Technology Holdings Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the healthcare technology and data services sector. The group focuses on technology-driven solutions and analytics for the medical and pharmaceutical markets in China, serving a range of industry participants with data, research and related value-added services.
Average Trading Volume: 7,013
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.19B
For detailed information about 2361 stock, go to TipRanks’ Stock Analysis page.